Short term MET effects on insulin resistance in type 2 diabetes mellitus.

Short term MET effects on insulin resistance in type 2 diabetes mellitus. - Short term MET effects on insulin resistance in T2DM

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007796

Enrollment

Registered

2012-04-20

Start date

2012-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus

Interventions

MET treatment (1.4 V/cm, 0.1ms, 55 pps, 42 degrees) for 60min.

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Type 2 diabetes mellitus (T2DM) i)Abdominal obesity, given as waist circumference greater than 85 cm ii)HbA1c more than 6.9%, less than 10.5% (NGSP)

Exclusion criteria

Exclusion criteria: i) Past history or current medication of myocardial infarction, angina, apoplexy and arteriosclerosis obliterans. ii)Severe wound, infections, pre- or post-operation. iii)Severe liver dysfunction (GOT and/or GPT: greater than 100U). iv)Chronic heart failure, familial dyslipidemia. v)Severe diabetic complications. vi)Pacemaker carrier.

Design outcomes

Primary

Measure	Time frame
glucose infusion rate	—

Countries

Japan

Contacts

Public ContactTatsuya Kondo

Kumamoto University, Faculty of Life Sciences. Metabolic Medicine

t-kondo@gpo.kumamoto-u.ac.jp096-373-5169

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026